head and neck cancer

2018 ASCO Annual Meeting; #ASCO18
May 16, 2018
Monika Sharda, ASCO staff

ASCO Annual Meeting 2018: A Preview of This Year’s Research

English
Monika.Sharda

Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.

Read More >>
February 16, 2018
Greg Guthrie, ASCO staff

Research on Quality of Life for Cancer Survivors

English
gregguthrie

In this podcast, Cancer.Net Specialty Editor Dr. Timothy Gilligan discusses some of the quality-of-life research featured at the 2018 Cancer Survivorship Symposium: Advancing Care and Research.

Read More >>
November 7, 2017
Greg Guthrie, ASCO staff

Did You Know Drinking Alcohol Increases Cancer Risk?

English
gregguthrie

In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

Read More >>
Holly Boykin; Voices on Cancer
April 13, 2017
Holly Boykin

Speaking Up for Head and Neck Cancer Awareness

English
Holly.Boykin

In this Voices on Cancer post, advocate Holly Boykin describes why building awareness of oral, head, and neck cancers can save lives and some of the tools she’s used to empower her advocacy career.

Read More >>
2017 Clinical Cancer Advances
February 1, 2017
Greg Guthrie, ASCO staff

Immunotherapy 2.0: The 2017 Clinical Cancer Advance of the Year

English
gregguthrie

The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.

Read More >>

Pages

Subscribe to RSS - head and neck cancer